Mallinckrodt (MNK) Tops Q2 EPS by 45c, Announces Suspension of Specialty Generics Spin-off
Tweet Send to a Friend
Mallinckrodt (NYSE: MNK) reported Q2 EPS of $2.53, $0.45 better than the analyst estimate of $2.08. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
